Mustafa ERDOĞAN, Seydahmet AKIN, Sinan KAZAN, Mehmet ALİUSTAOĞLU, Özcan KESKİN

Metabolik Alkalozla Prezente Olan Diyabetik Ketoasidoz

Giriş: Diyabet sıklığı ve prevelansı giderek artan bir hastalıktır. Diyabetin kronik ve akut komplikasyonları morbidite, mortalite ve artmış sağlık harcamalarına neden olmaktadır. Diyabetin önemli bir akut komplikasyonu genellikle ciddi organik asidoz ile ortaya çıkan diyabetik ketoasidozdur. Olgu Sunumu: Vakamızda diyabetik alkaloz ile tanı konan bir diyabetik ketoasidoz vakasını sunuyoruz. Sonuç: Biz bu vaka üzerinden, acil şartlarda miks kan gazı bozukluklarının değerlendirilmesine dikkat çekmeyi amaçladık.

Anahtar Kelimeler:

Diyabetik ketoasidoz, metabolik alkaloz, metabolik asidoz

Diabetic Ketoacidosis Presenting with Metabolic Alkalosis

Introduction: Diabetes is a disease with an increasing incidence and prevalence. Chronic and acute complications of diabetes cause mortality, morbidity, and increased health expenditure. A major acute complication of diabetes usually presenting with serious organic acidosis is diabetic ketoacidosis.Case Report: We report the case of a patient with diabetic ketoacidosis case who presented with diabetic metabolic alkalosis.Conclusion: Through this case, we aimed to draw attention to the assessment of mixed acid–base disturbances in emergency departments

Keywords:

Diabetic ketoacidosis, metabolic alkalosis, metabolic acidosis,

PDF

___

Jensen VF, Bİgh IB, Lykkesfeldt J. Effect of Insulin‐Induced Hypoglycaemia on the Central Nervous System: Evidence from Experimental Studies. J Neuroendocrinol 2014; 26: 123-50. [CrossRef]
Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve- year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28: 169-80. [CrossRef]
Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G. Metformin- associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci 2013; 17(Suppl 1): 45-9.
Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26: 1902-12. [CrossRef]
Wakim El KJ, Decosterd D. Toxicity of metformin, pro-or con-a future restriction to its contraindications? Rev Med Suisse 2013; 9: 1473-7.
Umpierrez, GE. Ketosis-Prone Type 2 Diabetes Time to revise the classification of diabetes. Diabetes Care 2006; 29: 2755-7. [CrossRef]
Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottmann M, Sondern KL, et al. Therapy of severe diabetic ketoacidosis. Zero-mortality under very- low-dose insulin application. Diabetes Care 1999; 22: 674-7. [CrossRef]
Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014; 370: 1514-23. [CrossRef]